JP2006519189A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519189A5 JP2006519189A5 JP2006501737A JP2006501737A JP2006519189A5 JP 2006519189 A5 JP2006519189 A5 JP 2006519189A5 JP 2006501737 A JP2006501737 A JP 2006501737A JP 2006501737 A JP2006501737 A JP 2006501737A JP 2006519189 A5 JP2006519189 A5 JP 2006519189A5
- Authority
- JP
- Japan
- Prior art keywords
- hsgk1
- gene
- hsgk3
- aliquots
- accession
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims 23
- 238000000034 method Methods 0.000 claims 15
- 239000000126 substance Substances 0.000 claims 10
- 101100393884 Drosophila melanogaster Glut1 gene Proteins 0.000 claims 8
- 102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 claims 8
- 108091052347 Glucose transporter family Proteins 0.000 claims 8
- 101150058068 SLC2A1 gene Proteins 0.000 claims 8
- 239000000758 substrate Substances 0.000 claims 7
- 238000012360 testing method Methods 0.000 claims 7
- 208000002177 Cataract Diseases 0.000 claims 6
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 6
- 208000010412 Glaucoma Diseases 0.000 claims 6
- 102000039446 nucleic acids Human genes 0.000 claims 6
- 108020004707 nucleic acids Proteins 0.000 claims 6
- 150000007523 nucleic acids Chemical class 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 102100035493 E3 ubiquitin-protein ligase NEDD4-like Human genes 0.000 claims 4
- 101710155393 E3 ubiquitin-protein ligase NEDD4-like Proteins 0.000 claims 4
- 239000005557 antagonist Substances 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 230000026731 phosphorylation Effects 0.000 claims 4
- 238000006366 phosphorylation reaction Methods 0.000 claims 4
- 238000012216 screening Methods 0.000 claims 4
- 230000001225 therapeutic effect Effects 0.000 claims 4
- 238000012258 culturing Methods 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- 101710165986 Negative regulator of transcription Proteins 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000006225 natural substrate Substances 0.000 claims 1
- 230000000865 phosphorylative effect Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 108700026220 vif Genes Proteins 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10305212A DE10305212A1 (de) | 2003-02-07 | 2003-02-07 | Verwendung der sgk-Genfamilie zur Diagnose und zur Therapie von Katarakt und Glaukom |
| PCT/EP2004/001048 WO2004069258A2 (de) | 2003-02-07 | 2004-02-05 | Verwendung der sgk-genfamilie zur diagnose und zur therapie von katarakt und glaukom |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519189A JP2006519189A (ja) | 2006-08-24 |
| JP2006519189A5 true JP2006519189A5 (enExample) | 2007-03-08 |
Family
ID=32730900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006501737A Pending JP2006519189A (ja) | 2003-02-07 | 2004-02-05 | 白内障および緑内障を診断および治療するための、ｓｇｋ遺伝子ファミリーの使用 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1663246A2 (enExample) |
| JP (1) | JP2006519189A (enExample) |
| KR (1) | KR20050114214A (enExample) |
| CN (1) | CN1771039A (enExample) |
| AU (1) | AU2004210416A1 (enExample) |
| BR (1) | BRPI0407300A (enExample) |
| CA (1) | CA2514703A1 (enExample) |
| DE (1) | DE10305212A1 (enExample) |
| MX (1) | MXPA05008394A (enExample) |
| PL (1) | PL378399A1 (enExample) |
| RU (1) | RU2005127808A (enExample) |
| WO (1) | WO2004069258A2 (enExample) |
| ZA (1) | ZA200506280B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1964705A (zh) * | 2004-03-11 | 2007-05-16 | 默克专利有限公司 | 干扰纤维化的方法 |
| RU2006135654A (ru) * | 2004-03-11 | 2008-09-10 | Мерк Патент ГмбХ (DE) | Способы модуляции глутаматных рецепторов для лечения нейропсихиатрических расстройств, включающие применение модуляторов сывороточных и индуцируемых глюкокортикоидами киназ |
| DE102004059781A1 (de) * | 2004-12-10 | 2006-06-22 | Sanofi-Aventis Deutschland Gmbh | Verwendung der Serum-/Glucocorticoid regulierten Kinase |
| WO2007002670A2 (en) * | 2005-06-28 | 2007-01-04 | Bausch & Lomb Incorporated | Method of lowering intraocular pressure |
| JPWO2007037560A1 (ja) * | 2005-09-30 | 2009-04-16 | リンク・ジェノミクス株式会社 | Ｓｇｋ２遺伝子の治療的又は診断的用途 |
| JP5249774B2 (ja) * | 2005-11-22 | 2013-07-31 | マギル ユニバーシティ | 眼内圧調節初期遺伝子およびその使用 |
| WO2008079980A1 (en) * | 2006-12-22 | 2008-07-03 | Alcon Research, Ltd. | Inhibitors of protein kinase c-delta for the treatment of glaucoma |
| DE102008029072A1 (de) * | 2008-06-10 | 2009-12-17 | Lang, Florian, Prof. Dr.med. | Sgk3 als therapeutisches und diagnostisches Target für Alterserkrankungen |
| BR112013018374A2 (pt) * | 2011-01-25 | 2016-10-11 | Monell Chemical Senses Centre | composições e métodos para fornecer ou modular o sabor doce e métodos para rastrear os mesmos |
| KR102357260B1 (ko) * | 2020-12-10 | 2022-02-08 | 주식회사 레피겐엠디 | 마이크로rna를 이용한 당뇨병성 신경병증의 예측 및 진단 방법 및 이를 위한 키트 |
| CN119303113A (zh) * | 2024-09-03 | 2025-01-14 | 河北大学附属医院 | Nedd4l基因在制备治疗血管内皮细胞增生性相关疾病药物中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996006863A1 (en) * | 1994-08-30 | 1996-03-07 | University Of Dundee | Agents for inducing apoptosis and applications of said agents in therapy |
| AU6263996A (en) * | 1995-06-07 | 1996-12-30 | Ligand Pharmaceuticals Incorporated | Method for screening for receptor agonists and antagonists |
| US5925523A (en) * | 1996-08-23 | 1999-07-20 | President & Fellows Of Harvard College | Intraction trap assay, reagents and uses thereof |
| DE19708173A1 (de) * | 1997-02-28 | 1998-09-03 | Dade Behring Marburg Gmbh | Zellvolumenregulierte humane Kinase h-sgk |
| WO1999059559A1 (en) * | 1998-05-15 | 1999-11-25 | Joslin Diabetes Center | Independent regulation of basal and insulin-stimulated glucose transport |
| DE69937159T2 (de) * | 1998-12-14 | 2008-06-26 | University Of Dundee, Dundee | Verfahren zur Aktivierung von SGK durch Phosphorylierung. |
| US6399655B1 (en) * | 1998-12-22 | 2002-06-04 | Johns Hopkins University, School Of Medicine | Method for the prophylactic treatment of cataracts |
| DE19917990A1 (de) * | 1999-04-20 | 2000-11-02 | Florian Lang | Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk |
| WO2001004145A2 (en) * | 1999-07-14 | 2001-01-18 | University Of Lausanne | Glutx polypeptide family and nucleic acids encoding same |
| US6416759B1 (en) * | 1999-09-30 | 2002-07-09 | The Regents Of The University Of California | Antiproliferative Sgk reagents and methods |
| US20030236246A1 (en) * | 2002-04-30 | 2003-12-25 | Brazzell Romulus Kimbro | Method for decreasing capillary permeability in the retina |
| DE10225844A1 (de) * | 2002-06-04 | 2003-12-18 | Lang Florian | sgk und nedd als diagnostische und therapeutische targets |
-
2003
- 2003-02-07 DE DE10305212A patent/DE10305212A1/de not_active Withdrawn
-
2004
- 2004-02-05 AU AU2004210416A patent/AU2004210416A1/en not_active Abandoned
- 2004-02-05 WO PCT/EP2004/001048 patent/WO2004069258A2/de not_active Ceased
- 2004-02-05 PL PL378399A patent/PL378399A1/pl not_active Application Discontinuation
- 2004-02-05 CN CNA2004800070348A patent/CN1771039A/zh active Pending
- 2004-02-05 MX MXPA05008394A patent/MXPA05008394A/es unknown
- 2004-02-05 KR KR1020057014582A patent/KR20050114214A/ko not_active Withdrawn
- 2004-02-05 EP EP04708350A patent/EP1663246A2/de not_active Withdrawn
- 2004-02-05 JP JP2006501737A patent/JP2006519189A/ja active Pending
- 2004-02-05 BR BR0407300-2A patent/BRPI0407300A/pt not_active IP Right Cessation
- 2004-02-05 RU RU2005127808/15A patent/RU2005127808A/ru not_active Application Discontinuation
- 2004-02-05 CA CA002514703A patent/CA2514703A1/en not_active Abandoned
-
2005
- 2005-08-05 ZA ZA200506280A patent/ZA200506280B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McCooke et al. | A novel mutation causing nephronophthisis in the Lewis polycystic kidney rat localises to a conserved RCC1 domain in Nek8 | |
| JP6448149B2 (ja) | 肝線維症に関連する遺伝的多型、その検出方法および使用 | |
| Riazuddin et al. | Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p | |
| Zhao et al. | Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs | |
| CN102177436B (zh) | 鉴定疾病风险因子的方法 | |
| JP2006519189A5 (enExample) | ||
| WO2012107580A1 (en) | In vitro diagnosis method for predicting a predisposition to cardiomyopathy | |
| Kaukonen et al. | A putative silencer variant in a spontaneous canine model of retinitis pigmentosa | |
| ES2373044T3 (es) | Procedimientos y composiciones para predecir la respuesta a warfarina. | |
| Gnaien et al. | A gain-of-function mutation in zinc cluster transcription factor Rob1 drives Candida albicans adaptive growth in the cystic fibrosis lung environment | |
| Kato et al. | Association of single-nucleotide polymorphisms in the suppressor of cytokine signaling 2 (SOCS2) gene with type 2 diabetes in the Japanese | |
| Cunnington et al. | STK39 polymorphisms and blood pressure: an association study in British Caucasians and assessment of cis-acting influences on gene expression | |
| RU2005127808A (ru) | Применение генов семейства sgk для диагностики и терапии катаракты и глаукомы | |
| Harold et al. | Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease | |
| CN103667301B (zh) | 冠心病相关基因及其体外检测的试剂、制剂或试剂盒、应用 | |
| Shaikh et al. | A new locus for nonsyndromic deafness DFNB51 maps to chromosome 11p13-p12 | |
| Goldsmith et al. | The sound of silence: autosomal recessive congenital ichthyosis caused by a synonymous mutation in ABCA 12 | |
| Rios Coronado et al. | CXCL12 drives natural variation in coronary artery anatomy across diverse populations | |
| US20060100132A1 (en) | Method for diagnosing inflammatory bowel disease | |
| Barral et al. | Expanded genome scan in extended families with age-related macular degeneration | |
| US10704098B2 (en) | Diagnosis and treatment of genetic alterations associated with eosinophilic esophagitis | |
| Takeuchi et al. | Search of type 2 diabetes susceptibility gene on chromosome 20q | |
| Zennaro et al. | Overview of aldosterone-related genetic syndromes and recent advances | |
| WO2012044987A2 (en) | Genetic modifiers of cystic fibrosis | |
| Li et al. | Polymorphisms of presenilin-1 gene associate with dilated cardiomyopathy susceptibility |